| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |